FIELD: biotechnologies.
SUBSTANCE: disclosed is recombinant plasmid pCpG-CytDA/upp with nucleotide sequence SEQ ID NO: 1, providing expression of hybrid protein citozindezaminaze E.coli-uracilphosforybozyl transferase. Disclosed is recombinant plasmid pCpG-CytDA/upp/VP22 with nucleotide sequence SEQ ID NO: 2, providing expression of hybrid protein citozindezaminaze e.coli-uracilphosforybozyl transferase-protein VP22 of individual. Also disclosed is composition containing mesenchymal stem/stromal cells, in which there is one of above plasmids.
EFFECT: group of inventions provides higher efficiency and safety of using mesenchymal stem/stromal cells expressing citozindezaminaze for therapy of tumours of various etiologies.
7 cl, 4 dwg, 2 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIGENIC COMPOSITION AND THERAPEUTIC APPLICATION THEREOF FOR PREVENTING AND TREATING ONCOLOGICAL DISEASES, RECOMBINANT PLASMID DNA, PROVIDING SYNTHESIS OF HYBRID PROTEIN, AS WELL AS METHOD OF PRODUCING PROTEIN | 2013 |
|
RU2590701C2 |
| UNIVERSAL PROMOTER FOR EXPRESSION OF THERAPEUTIC GENES IN MAMMALIAN CELLS | 2013 |
|
RU2551784C1 |
| RECOMBINANT VECTOR FOR CREATION OF PLASMID GENETIC STRUCTURES WITH INCREASED DURATION OF EXPRESSION OF TARGET GENES | 2018 |
|
RU2686102C1 |
| GENETIC CASSETTE CONTAINING CODON-OPTIMIZED NUCLEOTIDE SEQUENCES OF TRAIL, PTEN AND IFNβ-1 GENES, AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ONCOLOGIC DISEASES | 2020 |
|
RU2757502C1 |
| IMMUNOBIOLOGICAL AGENT TO ENHANCE CELLULAR RESPONSE AGAINST HEPATITIS C VIRUS | 2023 |
|
RU2811136C1 |
| COMBINATION THERAPY FOR CANCER TREATMENT USING RECOMBINANT MVA AND ANTIBODIES INTRODUCED INTRAVENOUSLY | 2018 |
|
RU2795103C2 |
| PROMOTER FOR TISSUE-SPECIFIC GENE EXPRESSION IN TERMINAL MAMMAL TISSUES | 2010 |
|
RU2459870C2 |
| NEW MOLECULE ASSOCIATED WITH HUMAN METASTATIC TUMOUR, METHODS FOR DETECTING BOTH ACTIVATED GENE, AND PROTEIN, AND PREVENTING GENE EXPRESSION | 2009 |
|
RU2546000C2 |
| METHOD OF THE MELANOMA TUMOR NODES FORMATION IN THE BODY OF EXPERIMENTAL ANIMALS | 2022 |
|
RU2796892C1 |
| EXPRESSIONAL PLASMID LENTIVIRAL VECTOR FOR HETEROLOGICAL EXPRESSION OF RECOMBINANT HUMAN PROTEIN CD47 | 2015 |
|
RU2627181C2 |
